Watch Nathan’s IXperience.
This information is based on Nathan's experience. Different patients may have different results. Talk to your doctor about whether IXINITY may be right for you.
9 Reasons why IXINITY was right for Nathan
In a clinical trial, 71% of bleeding episodes were resolved with 1 infusion and 13% were resolved with 2 infusions.1 Individual response may vary.
The average terminal half-life of IXINITY is 24 hours.1 Individual response may vary.
Consult a healthcare professional before beginning new activities.
IXINITY recovery is an average based on lab tests of patients in the clinical study.1 Your actual recovery and dose may be different. Speak with your healthcare professional about the right dose for you.
IXINITY has an average incremental recovery of 98%. Higher recovery may allow lower doses.1 Individual response may vary.
This information is based on Nathan’s experience. Different patients may have different results. Talk to your doctor about whether IXINITY may be right for you.
Selected Important Safety Information
Call your healthcare provider right away about any side effects that bother you or do not go away, or if your bleeding does not stop after taking IXINITY. The most common side effect that was reported with IXINITY during clinical trials was headache. These are not all the side effects possible with IXINITY. You can ask your healthcare provider for information that is written for healthcare professionals.
Reference: 1. IXINITY [coagulation factor IX (recombinant)] prescribing information. Berwyn, PA: Aptevo BioTherapeutics LLC; April 2018.